Core Insights - Huawei is set to launch its "Smart Medical Zone" as part of its industry AI "Dream Factory" plan on February 1, 2026, at the Medical AI Collaborative Innovation Forum in Shanghai [1][3] - The initiative aims to address the shortage of pathology doctors in China, where there are currently fewer than 20,000 registered pathologists, with a shortfall of 140,000, and 80% of these professionals are concentrated in major cities [3] Group 1 - The Smart Medical Zone will integrate top medical resources with AI technology to tackle structural challenges in pathology diagnosis, such as talent shortages and uneven resource distribution [1][3] - Since 2021, Huawei has partnered with Shanghai Ruijin Hospital to develop the pathology AI field, establishing China's first digital smart pathology department and planning to release a clinical-level pathology model, RuiPath, covering over 90% of common cancer types by 2025 [3] - The launch of the Smart Medical Zone signifies Huawei's commitment to consolidating ecosystem forces and positioning itself at the forefront of the national strategy for "AI + Healthcare," aiming to break down barriers in medical resources and scale AI capabilities to grassroots medical institutions [3]